Literature DB >> 4022126

Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.

J Bonadio, P H Byers.   

Abstract

Although the perinatal lethal form of osteogenesis imperfecta (OI type II) occasionally results from large rearrangements within the genes encoding type I collagen, most mutations are far more subtle. The complexity of the human collagen genes precludes cloning and sequencing each gene from every patient, and we have therefore developed an approach to localizing mutations at the protein level. We report here that cells cultured from 15 infants with OI type II synthesized both normal type I procollagen and a form that was unstable, poorly secreted and excessively modified. Abnormal procollagen from different strains was overmodified to different extents. The patterns of overmodification we observed are best explained by mutations that disrupt the Gly-X-Y sequence of pro alpha chains, and thus alter the rate of propagation of triple helix from COOH-terminus to NH2-terminus. As a consequence, a given mutation allows overmodification of all three chains in a molecule NH2-terminal to its position in the triple helix.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4022126     DOI: 10.1038/316363a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  70 in total

1.  A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV.

Authors:  A J Richards; J C Lloyd; P Narcisi; P N Ward; A C Nicholls; A De Paepe; F M Pope
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

2.  Purification and reconstitution of a collagen-binding heat-shock glycoprotein from L6 myoblasts.

Authors:  J P Vaillancourt; G A Cates
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

3.  Location of glycine mutations within a bacterial collagen protein affects degree of disruption of triple-helix folding and conformation.

Authors:  Haiming Cheng; Shayan Rashid; Zhuoxin Yu; Ayumi Yoshizumi; Eileen Hwang; Barbara Brodsky
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

4.  Osteogenesis imperfecta due to recurrent point mutations at CpG dinucleotides in the COL1A1 gene of type I collagen.

Authors:  C J Pruchno; D H Cohn; G A Wallis; M C Willing; B J Starman; X M Zhang; P H Byers
Journal:  Hum Genet       Date:  1991-05       Impact factor: 4.132

5.  Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybrids.

Authors:  D K Grange; G S Gottesman; M B Lewis; J C Marini
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

6.  Marfan syndrome: defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts.

Authors:  D M Milewicz; R E Pyeritz; E S Crawford; P H Byers
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

7.  A mutation causing Alport syndrome with tardive hearing loss is common in the western United States.

Authors:  D F Barker; C J Pruchno; X Jiang; C L Atkin; E M Stone; J C Denison; P R Fain; M C Gregory
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

8.  Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta.

Authors:  J M Pace; C D Kuslich; M C Willing; P H Byers
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

9.  COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.

Authors:  Aileen M Barnes; Aarthi Ashok; Elena N Makareeva; Marina Brusel; Wayne A Cabral; MaryAnn Weis; Catherine Moali; Emmanuel Bettler; David R Eyre; John P Cassella; Sergey Leikin; David J S Hulmes; Efrat Kessler; Joan C Marini
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-05-02       Impact factor: 5.187

10.  Osteogenesis imperfecta type IIA: evidence for dominant inheritance.

Authors:  I D Young; E M Thompson; C M Hall; M E Pembrey
Journal:  J Med Genet       Date:  1987-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.